MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$208,273K
(-28.38%↓ Y/Y)
Net loss
-$206,031K
(-27.67%↓ Y/Y)
Unrealized gain on
available-for-sale securities, net
-$1,838K
(-239.74%↓ Y/Y)
Foreign currency
translation adjustments
-$404K
(-29.49%↓ Y/Y)
Interest and other
income, net
$11,022K
(-19.55%↓ Y/Y)
License And Milestone
Revenues
$11,929K
Net Product Revenue
$4,789K
Collaboration Revenues
$2,637K
Change in fair value of
derivative liabilities
$1,500K
(475.00%↑ Y/Y)
Operating loss
-$183,618K
(-17.98%↓ Y/Y)
Non-cash interest
expense on liabilities...
$18,816K
(33.66%↑ Y/Y)
Interest and other
expense, net
$14,519K
(63.72%↑ Y/Y)
Total revenues
$19,355K
(1125.78%↑ Y/Y)
Change in fair value of
liabilities related to rpi...
-$1,600K
(-141.03%↓ Y/Y)
Total operating
expenses
$202,973K
(29.11%↑ Y/Y)
Selling, general and
administrative
$104,896K
Research and development
$95,525K
(-4.32%↓ Y/Y)
Collaboration cost of sales
$2,392K
Cost of goods sold
$160K
Back
Back
Income Statement
CYTOKINETICS INC (CYTK)
CYTOKINETICS INC (CYTK)
source: myfinsight.com